Suppr超能文献

颈部影像学报告和数据系统分类 3 和 4 后治疗 FDG-PET/CT 在头颈部鳞状细胞癌中的阳性预测值。

Positive Predictive Value of Neck Imaging Reporting and Data System Categories 3 and 4 Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.

机构信息

From the Departments of Radiology (P.W., B.F.B., J.D.L.).

Otolaryngology (B.F.B., U.D., D.E.H.).

出版信息

AJNR Am J Neuroradiol. 2020 Jun;41(6):1070-1075. doi: 10.3174/ajnr.A6589. Epub 2020 May 28.

Abstract

BACKGROUND AND PURPOSE

The Neck Imaging Reporting and Data System is a standardized reporting system intended to risk stratify patients treated for head and neck squamous cell carcinoma. The purpose of this study is to investigate the positive predictive value of the Neck Imaging Reporting and Data System categories 3 and 4 on posttreatment PET/CT in patients treated definitively for head and neck squamous cell carcinoma.

MATERIALS AND METHODS

We retrospectively identified patients treated definitively for head and neck squamous cell carcinoma between 2006 and 2018. Patients whose posttreatment PET/CT scans were interpreted as Neck Imaging Reporting and Data System 3 (suspicious) or 4 (definitive recurrence) at the primary site, regional nodes, or at distant sites were included. The reference standard was histopathology or unequivocal imaging or clinical evidence of treatment failure. The positive predictive values of Neck Imaging Reporting and Data System 3 and 4 posttreatment PET/CT were calculated.

RESULTS

Seventy-two of 128 patients with posttreatment PET/CT interpreted as Neck Imaging Reporting and Data System 3 at the primary site, regional nodes, or distant sites were proved to have treatment failure at the suspicious sites, yielding an overall positive predictive value of 56% (95% CI, 48%-65%). The positive predictive values of Neck Imaging Reporting and Data System 3 by subsite were as follows: primary site, 56% (44/79); regional nodes, 65% (34/52); and distant sites, 79% (42/53). All 69 patients with posttreatment PET/CT interpreted as Neck Imaging Reporting and Data System 4 had true treatment failure, yielding a positive predictive value of 100% (95% CI, 96%-100%): primary site, 100% (28/28); regional nodes, 100% (32/32); and distant sites, 100% (29/29).

CONCLUSIONS

The positive predictive value of Neck Imaging Reporting and Data System 3 on posttreatment PET/CT is relatively low. Thus, Neck Imaging Reporting and Data System 3 findings should be confirmed with tissue sampling before instituting new salvage treatment regimens to avoid unnecessary overtreatment and its associated toxicities. Neck Imaging Reporting and Data System 4 reliably indicates recurrent disease.

摘要

背景与目的

颈部成像报告和数据系统(Neck Imaging Reporting and Data System,NIRADS)是一种标准化的报告系统,旨在对接受头颈部鳞状细胞癌治疗的患者进行风险分层。本研究的目的是探讨在接受根治性治疗的头颈部鳞状细胞癌患者中,NIRADS 分类 3 和 4 在治疗后 PET/CT 上的阳性预测值。

材料与方法

我们回顾性地确定了 2006 年至 2018 年期间接受根治性治疗的头颈部鳞状细胞癌患者。将治疗后 PET/CT 扫描在原发部位、区域淋巴结或远处部位被解读为 NIRADS 3(可疑)或 4(明确复发)的患者纳入研究。参考标准是组织病理学或明确的影像学或治疗失败的临床证据。计算了治疗后 NIRADS 3 和 4 PET/CT 的阳性预测值。

结果

在治疗后 PET/CT 被解读为原发部位、区域淋巴结或远处部位 NIRADS 3 的 128 例患者中,有 72 例在可疑部位证实存在治疗失败,总体阳性预测值为 56%(95%CI,48%-65%)。NIRADS 3 的亚部位阳性预测值如下:原发部位,56%(44/79);区域淋巴结,65%(34/52);远处部位,79%(42/53)。所有治疗后 PET/CT 被解读为 NIRADS 4 的 69 例患者均有真正的治疗失败,阳性预测值为 100%(95%CI,96%-100%):原发部位,100%(28/28);区域淋巴结,100%(32/32);远处部位,100%(29/29)。

结论

治疗后 PET/CT 上 NIRADS 3 的阳性预测值相对较低。因此,在制定新的挽救治疗方案之前,应通过组织取样来确认 NIRADS 3 结果,以避免不必要的过度治疗及其相关毒性。NIRADS 4 可靠地提示疾病复发。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验